About the HPTN

Mission Statement

The HPTN is dedicated to the discovery and development of new and innovative research strategies to reduce the acquisition and transmission of HIV.

The HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network that brings together investigators, ethicists, community and other partners to develop and test the safety and efficacy of interventions designed to prevent the acquisition and transmission of HIV. HPTN studies evaluate new HIV prevention interventions and strategies in populations and geographical regions that bear a disproportionate burden of infection.

The HPTN research agenda is focused primarily on the use of integrated strategies: use of antiretroviral drugs (antiretroviral therapy and pre-exposure prophylaxis); interventions for substance abuse, particularly injection drug use; behavioral risk reduction interventions and structural interventions. The HPTN is committed to the highest ethical standards for its clinical trials and recognizes the importance of community engagement in all phases of the research process.

The HPTN was established in 2000, building on the work of the HIV Network for Prevention Trials (HIVNET). HPTN’s Leadership and Operations Center (LOC), is based at FHI 360, Durham, North Carolina. Its Laboratory Center (LC) is at Johns Hopkins University, Baltimore, Maryland and its Statistical and Data Management Center (SDMC) is housed within the Statistical Center for HIV/AIDS Research and Prevention (SCHARP) at the Fred Hutchinson Cancer Research Center in Seattle, Washington. The HPTN Modelling Centre, part of the SDMC, is a collaboration between the Department of Infectious Diseases Epidemiology at Imperial College London and SCHARP.

HPTN receives its funding from three NIH institutes: the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health and the National Institute on Drug Abuse.

Webinars

The HPTN Leadership and Operations Center (LOC)

The HPTN Statistical and Data Management Center (SDMC)


Conversations with the HPTN

Melissa M. Turner, MSW, LICSW, MPA, chair of the HPTN Community Working Group and HPTN Executive Committee member, has been integrally involved in patient care management and HIV clinical trials for more than 20 years.

Mia Ryan Porter, a member of the HPTN 083 and HPTN 091

Calvin Mbeda, a member of the HPTN 075 study team and study coordinator at the Kisumu CRS in Kisumu, Kenya, has supported HIV prevention research community efforts since 2010.

DeMarcus Jones is an HPTN 083 and HPTN 083-01 outreach recruiter at St.